ARCHIVES

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Obama Administration, WellPoint, Face Off Over Allegation Of Coverage Recissions

April 30, 2010

Other ASCO Plenary Papers: Long Awaited Chemotherapy Results

June 12, 1992

Controversial Dr. Rajika Medencica Sued By Patient; Hilton Head hospital Reviews His Practices

April 30, 1993

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

December 2, 1988

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998